eli lilly tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly, Maker of Mounjaro

If you have any questions or are unsure about how to use weight loss injectable device, you should speak to your healthcare provider

Forward-Looking Statements: This article reflects HumeCare's publicly available materials as of July 2026

Send us a message and well be in touch.

Most patients experience improvement within 24 weeks as their body adjusts

If the metabolism of ethanol in other organs is not reduced by GLP-1R agonists, then it is possible that the elevated blood levels caused by reduced hepatic metabolism could have detrimental effects on other organs, shifting ethanol metabolism and production of acetaldehyde from the liver to other organs